TQH2929 Injection

· Chia Tai Tianqing Pharmaceutical Group / Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQH2929 Injection, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) [Phase 1]